Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
13:50:45 EDT Thu 20 Mar 2025
Enter Symbol
or Name
USA
CA



Forgot password?
Trouble logging in?
Login ID:
Password:
Save

T:TH - THERATECHNOLOGIES INC. - https://www.theratech.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
TH - T  0.32.28·2.310.92.29+0.031.3196.54351792.24  2.37  2.223.13  1.5913:16:58Mar 1215 min RT 2¢
TSX - T0.32.28·2.310.92.29+0.031.324.454772.24  2.37  2.223.13  1.5913:16:5815 min
NEO ATS - U 2.29+0.031.37.617142.25  2.32  2.2513:16:5815 min
Alpha - A 2.32+0.062.716.939102.28  2.36  2.2712:25:5615 min
Omega - O 2.27+0.010.40.4122.25  2.27  2.2511:39:5315 min
Pure - P 2.29+0.031.30.3132.24  2.29  2.2411:43:5015 min
Chi-X - X 2.315+0.0552.4138.9308352.23  2.37  2.2312:48:2815 min
CX2 - H 2.33+0.073.16.414182.25  2.33  2.2511:53:5715 min
CXD - D 2.315+0.0552.40.71102.285  2.33  2.28513:07:2115 min
TriAct - M 2.260.828    Sep 11-2015 min
CS2 - S 2.25-0.01-0.40.1022.25  2.25  2.2511:36:5015 min

Recent Trades - Last 10 of 179
Time ETExPriceChangeVolumeBuyerSellerMarkers
13:16:58U2.290.0380079 CIBC1 AnonymousK
13:16:58U2.290.0380079 CIBC1 AnonymousK
13:16:58T2.290.0310079 CIBC1 AnonymousK
13:16:58T2.290.0310079 CIBC1 AnonymousK
13:16:52T2.300.0450085 Scotia79 CIBCK
13:16:52T2.310.0560079 CIBC1 AnonymousK
13:16:52T2.320.0610065 Goldman1 AnonymousK
13:07:21D2.3150.05510079 CIBC79 CIBCK
13:07:21T2.3150.05520039 Merrill Lynch79 CIBCK
13:07:21T2.320.0620039 Merrill Lynch79 CIBCK

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolPriceTypeHeadline
2025-03-12 14:33C:TH2.18News ReleaseTheratechnologies talks CV study in people with HIV
2025-03-12 14:14C:TH2.18News ReleaseTheratechnologies talks ibalizumab study on HIV RNA
2025-02-26 08:30C:TH2.59SEDAR Annual ReportSEDAR Annual Report
2025-02-26 08:19C:TH2.59SEDAR Audited Annual Financial StatementsSEDAR Audited Annual Financial Statements
2025-02-26 08:19C:TH2.59SEDAR MD & ASEDAR MD & A
2025-02-26 07:30C:TH2.59News ReleaseTheratechnologies Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2024
2025-02-14 10:23C:TH2.31News ReleaseTheratechnologies to issue fiscal 2024 results Feb. 26
2025-02-13 19:52C:TH2.31News ReleaseTheratechnologies resumes distribution of Egrifta
2025-01-09 18:16C:TH2.92News ReleaseTheratechnologies warns of impending Egrifta shortage
2024-12-18 18:47C:TH2.56News ReleaseTheratechnologies files prior approval supplement
2024-12-10 20:24C:TH2.03News ReleaseTheratechnologies' F8 formulation aimed for March 25
2024-12-09 16:52C:TH2.14News ReleaseTheratechnologies posts data from phase 1b TH1902 trial
2024-12-04 16:54C:TH2.00News ReleaseTheratechnologies signs licensing deal with Ionis
2024-12-03 16:42C:TH1.85News ReleaseTheratechnologies resumes production of Egrifta
2024-12-02 17:42C:TH1.82News ReleaseTheratechnologies closes $75M (U.S.) in new facilities
2024-11-26 16:24C:TH1.74News ReleaseTheratechnologies submits updated application to FDA
2024-10-17 17:36C:TH1.76News ReleaseTheratechnologies releases CVD data from presentations
2024-10-17 14:01C:TH1.76News ReleaseTheratechnologies talks Promise-U.S. study design
2024-10-10 14:54C:THSEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2024-10-10 14:54C:THSEDAR Interim MD & ASEDAR Interim MD & A